Emergent BioSolutions
(NYSE:EBS)
$1.955
0.055[2.89%]
Last update: 12:08PM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Emergent BioSolutions Stock (NYSE:EBS), Quotes and News Summary

Emergent BioSolutions Stock (NYSE: EBS) stock price, news, charts, stock research, profile.

Open$1.900
Close-
Volume / Avg.280.176K / 2.977M
Day Range1.850 - 1.980
52 Wk Range1.420 - 12.010
Market Cap$102.424M
P/E Ratio-
Dividend Yield-
ExchangeNYSE
RSI
38
Short Interest
13.32%
Days to Cover5.01

Recent News

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Avi Kapoor
Why Rush Street Interactive Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Shares of Rush Street Interactive, Inc. (NYSE: RSI) rose sharply in today’s pre-market trading as the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for 2024.
Avi Kapoor
Emergent BioSolutions Reports Q4 Results, Amends Credit Agreement
Emergent BioSolutions reported quarterly losses of 77 cents per share, missing the analyst consensus estimate of losses of 19 cents per share. Quarterly sales came in at $276.6 million which missed the analyst consensus estimate of $293.533 million and is a 16.36% decrease from the same period last year.
Erica Kollmann
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
1
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.3
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
About Emergent Biosolutions Inc
Sector
Health Care
Industry
Biotechnology
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EBS
MOLN

FAQ

Q

How do I buy Emergent BioSolutions (EBS) stock?

A

You can purchase shares of Emergent BioSolutions (NYSE: EBS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Emergent BioSolutions's (EBS) competitors?

A

Other companies in Emergent BioSolutions’s space includes: Molecular Partners (NASDAQ:MOLN), Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Connect Biopharma Hldgs (NASDAQ:CNTB) and Cellectar Biosciences (NASDAQ:CLRB).

Q

What is the target price for Emergent BioSolutions (EBS) stock?

A

The latest price target for Emergent BioSolutions (NYSE: EBS) was reported by Benchmark on Thursday, April 11, 2024. The analyst firm set a price target for 5.00 expecting EBS to rise to within 12 months (a possible 160.42% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Emergent BioSolutions (EBS)?

A

The stock price for Emergent BioSolutions (NYSE: EBS) is $1.92 last updated April 17, 2024 at 6:35 PM EDT.

Q

Does Emergent BioSolutions (EBS) pay a dividend?

A

There are no upcoming dividends for Emergent BioSolutions.

Q

When is Emergent BioSolutions (NYSE:EBS) reporting earnings?

A

Emergent BioSolutions’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Q

Is Emergent BioSolutions (EBS) going to split?

A

There is no upcoming split for Emergent BioSolutions.

Q

What sector and industry does Emergent BioSolutions (EBS) operate in?

A

Emergent BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

People Also Watch